文献速递生殖医学

自然周期中自发排卵或诱导排卵的冻融胚胎移植:仍在寻找最佳方案

Frozen-thawed embryo transfers in natural cycles with spontaneous or induced ovulation: the search for the best protocol continues.
PubMed 文献 · Hum Reprod · 2016-10-25

本回顾性研究纳入2010年1月至2015年4月单中心2353个冻融胚胎移植周期,比较自然周期(NC)、自然周期+黄体期支持(NC+LPS)与改良自然周期+黄体期支持(mNC+LPS)的临床妊娠率。未调整临床妊娠率NC组46.9%显著高于mNC+LPS组29.7%(P<0.001),但与NC+LPS组39.9%无显著差异(P=0.069);调整混杂后mNC+LPS组仍显著较低。作者认为应重新考虑使用hCG触发或孕酮补充的mNC方案。

要点

  • NC-FET组未调整临床妊娠率46.9%,显著高于mNC+LPS组的29.7%(P<0.001)。
  • NC-FET组与NC-FET+LPS组临床妊娠率39.9%相比无显著差异(P=0.069)。
  • 调整混杂后mNC+LPS组临床妊娠率仍显著低于NC-FET组和NC-FET+LPS组。

核心结论

  • 与改良自然周期冻融胚胎移植相比,自然周期冻融胚胎移植与更高的临床妊娠率相关。
  • 作者认为,鉴于对妊娠结局的潜在负面影响,应重新考虑使用hCG触发或孕酮补充的改良自然周期冻融胚胎移植。

研究设计与样本

  • 回顾性研究,纳入2010年1月至2015年4月单中心连续2353个冻融胚胎移植周期,移植玻璃化冷冻的卵裂期和囊胚期胚胎。
  • 周期分为自然周期组(n=501)、自然周期+黄体期支持组(n=828)和改良自然周期+黄体期支持组(n=1024),排除人工周期。
  • 采用混合效应多水平多变量回归分析校正同一患者和/或同一卵巢刺激周期来源胚胎的聚类效应,并校正女性取卵年龄、获卵数、新鲜周期妊娠结局、移植次序、移植胚胎数、胚胎阶段和级别及内膜厚度等混杂因素。

主要发现

  • 未调整每周期临床妊娠率:自然周期组46.9%,显著高于改良自然周期+黄体期支持组的29.7%(P<0.001),但与自然周期+黄体期支持组的39.9%相比无显著差异(P=0.069)。
  • 调整潜在混杂因素后,改良自然周期+黄体期支持组的临床妊娠率仍显著较低,与自然周期组和自然周期+黄体期支持组相比的调整比值比(95%CI)分别为2.18(1.64-2.90)和1.67(1.31-2.12)。
  • 敏感性分析仅纳入夫妇在本中心首次冻融胚胎移植周期,多变量逻辑回归模型预测的临床妊娠率自然周期组为53.9%、自然周期+黄体期支持组为44.9%,均显著高于改良自然周期+黄体期支持组的34.2%(所有Bonferroni校正两两比较P≤0.01)。

临床怎么用

  • 作者认为,使用hCG触发或孕酮补充的改良自然周期冻融胚胎移植应重新考虑,因其对妊娠结局可能存在负面影响。

局限性

  • 研究结果的解读受限于分析的回顾性性质。
  • 存在潜在未测量混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is natural cycle frozen-thawed embryo transfer (NC-FET) associated with better clinical pregnancy rates (CPR) when compared to modified natural cycle frozen-thawed embryo transfer (mNC-FET)? SUMMARY ANSWER: NC-FET is associated with a higher CPR compared to mNC-FET. WHAT IS KNOWN ALREADY: There is conflicting evidence regarding the impact of hCG triggering on clinical outcomes after frozen-thawed embryo transfer (FET), and information on the effect of luteal phase support (LPS) is lacking. STUDY DESIGN, SIZE, DURATION: This retrospective study included all (n = 2353) consecutive cycles with FET of vitrified cleavage and blastocyst stage embryos warmed between January 2010 and April 2015 in a tertiary centre. The FET cycles were grouped by type as follows: NC (n = 501), NC + LPS (n = 828) or mNC + LPS (n = 1024). Artificial cycles were excluded from the analysis. PARTICIPANTS/MATERIALS, SETTING, METHODS: We performed mixed-effect multilevel multivariable regression analysis to account for the clustering of FETs using embryos derived from the same patient and/or ovarian stimulation cycle. Adjustment for the following potential confounders was also performed: female age at oocyte retrieval, number of oocytes retrieved, fresh cycle pregnancy outcome, embryo transfer rank, number of embryos transferred, embryo stage and grade and endometrial thickness. Bonferroni adjustment for multiple comparisons was performed whenever indicated. MAIN RESULTS AND THE ROLE OF CHANCE: The unadjusted CPR per cycle was significantly higher in the NC-FET group (46.9%) when compared with the mNC-FET + LPS groups (29.7%, P < 0.001) but not the NC-FET + LPS group (39.9%, P = 0.069). The lower clinical performance of mNC-FET + LPS remained significant even after adjusting for potential confounders [adjusted odds ratio (95% CI) compared to the NC-FET groups: 2.18 (1.64-2.90) and 1.67 (1.31-2.12) for the NC-FET and NC-FET + LPS groups, respectively]. A sensitivity analysis restricting the sample only to the first FET performed by the couple in our centre was also performed. The predicted CPR in this multivariable logistic regression model remained significantly higher in the NC-FET (53.9%) and NC-FET + LPS (44.9%) groups when compared to mNC-FET + LPS (34.2%, all Bonferroni-adjusted pairwise comparisons with P ≤ 0.01). LIMITATIONS, REASONS FOR CAUTION: The interpretation of the findings of this study is limited by the retrospective nature of the analysis and the potential for unmeasured confounding. WIDER IMPLICATIONS OF THE FINDINGS: The use of mNC-FET, using hCG triggering or progesterone supplementation, should be reconsidered in light of the potential negative effect on pregnancy outcome. STUDY FUNDING/COMPETING INTERESTS: None. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Montagut M, Santos-Ribeiro S, De Vos M, et al. Frozen-thawed embryo transfers in natural cycles with spontaneous or induced ovulation: the search for the best protocol continues. Hum Reprod. 2016. PMID: 27798046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。